Reproductive Intelligence Gap : An AI Driven Analysis of Personalised Health Inequities across Genders

ReproHealth AI represents a substantive advance in the application of artificial intelligence to reproductive health management. By combining the clinical reliability of rule-based medical logic, the linguistic intelligence of NLP, and the generative conversational capability of Google Gemini within a unified, clinically supervised architecture, the platform delivers a quality of personalised health support that no existing single-approach solution can match.   The platform's inclusive design philosophy — spanning gender, lifecycle stage, and relational context through the Couple Sync feature — addresses critical gaps in the existing digital reproductive health landscape. The three-cycle retrospective analysis methodology introduces a meaningful temporal intelligence dimension that elevates the platform's analytical outputs from reactive symptom logging to proactive, longitudinal health intelligence.   Perhaps most significantly, the Clinical Safety Layer positions ReproHealth AI not as a technology competing with healthcare professionals, but as an intelligent ally to both patients and clinicians — absorbing the burden of continuous health monitoring, providing structured health context for clinical encounters, and ensuring that AI-generated health information operates within carefully maintained clinical safety boundaries.   As the global healthcare system grapples with the dual challenges of rising demand and constrained clinical capacity, platforms like ReproHealth AI offer a compelling model for how AI can extend the reach of clinical care, empower patients with meaningful health intelligence, and contribute to measurably better reproductive health outcomes across diverse populations worldwide.

[1] World Health Organization. (2022). Reproductive health. WHO Global Health Observatory. World Health Organization.   [2] Topol, E. J. (2019). High-performance medicine: The convergence of human and artificial intelligence. Nature Medicine, 25(1), 44–56.   [3] Esteva, A., Kuprel, B., Novoa, R. A., Ko, J., Swetter, S. M., Blau, H. M., & Thrun, S. (2017). Dermatologist-level classification of skin cancer with deep neural networks. Nature, 542(7639), 115–118.   [4] Johnson, K. B., Wei, W. Q., Weeraratne, D., Frisse, M. E., Misulis, K., Rhee, K., ... & Snowdon, J. L. (2021). Precision medicine, AI, and the future of personalised health care. Clinical and Translational Science, 14(1), 86–93.   [5] Hamet, P., & Tremblay, J. (2017). Artificial intelligence in medicine. Metabolism, 69, S36–S40.   [6] Grigorescu, V., Hassanein, M., & Bhavsar, A. (2020). Reproductive health and digital technologies: A systematic review of mobile health applications. Journal of Medical Internet Research, 22(4), e16536.   [7] Brennan, R., & Conway, A. (2022). Menstrual cycle tracking applications: A review of clinical accuracy and user experience. npj Digital Medicine, 5(1), 1–9.   [8] Abbe, C. R., Smith, D. L., & Taitel, M. S. (2020). An assessment of male reproductive health applications: Gaps, opportunities, and design principles. JMIR mHealth and uHealth, 8(10), e19718.   [9] Kung, T. H., Cheatham, M., Medenilla, A., Sillos, C., De Leon, L., Elepaño, C., ... & Soroush, A. (2023). Performance of ChatGPT on USMLE: Potential for AI-assisted medical education using large language models. PLOS Digital Health, 2(2), e0000198.   [10] Sezgin, E., Sirrianni, J., Linwood, S. L., & Oh, H. (2022). Operationalising de-identified conversation data from a mental health support service chatbot for training conversational agents. JAMIA Open, 5(1), ooac020.